Welcome to the UPF Digital Repository

Missing diagnoses during the COVID-19 Pandemic: a year in review

Show simple item record

dc.contributor.author Pifarré Arolas, Héctor
dc.contributor.author Vidal Alaball, Josep
dc.contributor.author Gil, Joan
dc.contributor.author López Seguí, Francesc, 1991-
dc.contributor.author Nicodemo, Catia
dc.contributor.author Saez, Marc
dc.date.accessioned 2023-11-28T07:07:27Z
dc.date.available 2023-11-28T07:07:27Z
dc.date.issued 2021
dc.identifier.citation Pifarré i Arolas H, Vidal-Alaball J, Gil J, López F, Nicodemo C, Saez M. Missing diagnoses during the COVID-19 Pandemic: a year in review. IJERPH. 2021 May 2;18(10):5335. DOI: 10.3390/ijerph18105335
dc.identifier.issn 1660-4601
dc.identifier.uri http://hdl.handle.net/10230/58391
dc.description.abstract The COVID-19 pandemic has had major impacts on population health not only through COVID-positive cases, but also via the disruption of healthcare services, which in turn has impacted the diagnosis and treatment of all other diseases during this time. We study changes in all new registered diagnoses in ICD-10 groups during 2020 with respect to a 2019 baseline. We compare new diagnoses in 2019 and 2020 based on administrative records of the public primary health system in Central Catalonia, Spain, which cover over 400,000 patients and 3 million patient visits. We study the ratio of new diagnoses between 2019 and 2020 and find an average decline of 31.1% in new diagnoses, with substantial drops in April (61.1%), May (55.6%), and November (52%). Neoplasms experience the largest decline (49.7%), with heterogeneity in the magnitudes of the declines across different types of cancer diagnoses. While we find evidence of temporal variation in new diagnoses, reductions in diagnoses early in the year are not recouped by the year end. The observed decline in new diagnoses across all diagnosis groups suggest a large number of untreated and undetected cases across conditions. Our findings provide a year-end summary of the impact of the pandemic on healthcare activities and can help guide health authorities to design evidence-based plans to target under-diagnosed conditions in 2021.
dc.format.mimetype application/pdf
dc.language.iso eng
dc.publisher MDPI
dc.relation.ispartof International Journal of Environmental Research and Public Health. 2021 May 2;18(10):5335
dc.rights © 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
dc.rights.uri http://creativecommons.org/licenses/by/4.0/
dc.title Missing diagnoses during the COVID-19 Pandemic: a year in review
dc.type info:eu-repo/semantics/article
dc.identifier.doi http://dx.doi.org/10.3390/ijerph18105335
dc.subject.keyword Indirect impact
dc.subject.keyword Delayed diagnoses
dc.subject.keyword COVID-19
dc.subject.keyword SARS-CoV-2
dc.subject.keyword Access to healthcare
dc.rights.accessRights info:eu-repo/semantics/openAccess
dc.type.version info:eu-repo/semantics/publishedVersion


This item appears in the following Collection(s)

Show simple item record

Search DSpace

Advanced Search


My Account


In collaboration with Compliant to Partaking